Jungfleisch J, Gebauer F
RNA Biol. 2025; 22(1):1-8.
PMID: 40016176
PMC: 11869776.
DOI: 10.1080/15476286.2025.2470511.
Lv X, Sun X, Gao Y, Song X, Hu X, Gong L
J Exp Clin Cancer Res. 2025; 44(1):32.
PMID: 39885614
PMC: 11781073.
DOI: 10.1186/s13046-025-03279-w.
Bak-Gordon P, Manley J
RNA. 2025; 31(3):314-332.
PMID: 39773890
PMC: 11874996.
DOI: 10.1261/rna.080368.124.
Amorello A, Chandrashekar Reddy G, Melillo B, Cravatt B, Ghosh A, Jurica M
J Biol Chem. 2024; 301(2):108135.
PMID: 39725033
PMC: 11791315.
DOI: 10.1016/j.jbc.2024.108135.
Nguyen J, Drabarek W, Leeflang A, Brands T, van den Bosch T, Verdijk R
Invest Ophthalmol Vis Sci. 2024; 65(12):11.
PMID: 39374010
PMC: 11463709.
DOI: 10.1167/iovs.65.12.11.
Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism.
van den Bosch Q, Kilic E, Brosens E
Invest Ophthalmol Vis Sci. 2024; 65(10):26.
PMID: 39163035
PMC: 11346061.
DOI: 10.1167/iovs.65.10.26.
Exon inclusion signatures enable accurate estimation of splicing factor activity.
Anglada-Girotto M, Moakley D, Zhang C, Miravet-Verde S, Califano A, Serrano L
bioRxiv. 2024; .
PMID: 38979366
PMC: 11230296.
DOI: 10.1101/2024.06.21.600051.
Small molecules modulating RNA splicing: a review of targets and future perspectives.
Bouton L, Ecoutin A, Malard F, Campagne S
RSC Med Chem. 2024; 15(4):1109-1126.
PMID: 38665842
PMC: 11042171.
DOI: 10.1039/d3md00685a.
Small molecule inhibition of RNA binding proteins in haematologic cancer.
Jaiswal A, Thaxton M, Scherer G, Sorrentino J, Garg N, Rao D
RNA Biol. 2024; 21(1):1-14.
PMID: 38329136
PMC: 10857685.
DOI: 10.1080/15476286.2024.2303558.
RNA splicing alterations in lung cancer pathogenesis and therapy.
Yan Y, Ren Y, Bao Y, Wang Y
Cancer Pathog Ther. 2024; 1(4):272-283.
PMID: 38327600
PMC: 10846331.
DOI: 10.1016/j.cpt.2023.04.004.
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
Wheeler E, Martin B, Doyle W, Neaher S, Conway C, Pitton C
Sci Transl Med. 2024; 16(728):eade2774.
PMID: 38170787
PMC: 11222919.
DOI: 10.1126/scitranslmed.ade2774.
Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain.
Hunter O, Talkish J, Quick-Cleveland J, Igel H, Tan A, Kuersten S
RNA. 2023; 30(2):149-170.
PMID: 38071476
PMC: 10798247.
DOI: 10.1261/rna.079866.123.
Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain.
Hunter O, Talkish J, Quick-Cleveland J, Igel H, Tan A, Kuersten S
bioRxiv. 2023; .
PMID: 37873484
PMC: 10592967.
DOI: 10.1101/2023.10.05.560965.
From words to complete phrases: insight into single-cell isoforms using short and long reads.
Joglekar A, Foord C, Jarroux J, Pollard S, Tilgner H
Transcription. 2023; 14(3-5):92-104.
PMID: 37314295
PMC: 10807471.
DOI: 10.1080/21541264.2023.2213514.
Distinct regulatory functions and biological roles of lncRNA splice variants.
Khan M, Avino M, Wellinger R, Laurent B
Mol Ther Nucleic Acids. 2023; 32:127-143.
PMID: 37025931
PMC: 10070373.
DOI: 10.1016/j.omtn.2023.03.004.
SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process.
Jiang M, Chen M, Liu Q, Jin Z, Yang X, Zhang W
Front Oncol. 2023; 13:1116438.
PMID: 37007111
PMC: 10063959.
DOI: 10.3389/fonc.2023.1116438.
Re-evaluating the impact of alternative RNA splicing on proteomic diversity.
Manuel J, Guilloy N, Khatir I, Roucou X, Laurent B
Front Genet. 2023; 14:1089053.
PMID: 36845399
PMC: 9947481.
DOI: 10.3389/fgene.2023.1089053.
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition.
Aptullahoglu E, Ciardullo C, Wallis J, Marr H, Marshall S, Bown N
Int J Mol Sci. 2023; 24(3).
PMID: 36768733
PMC: 9916657.
DOI: 10.3390/ijms24032410.
Targeting splicing factors for cancer therapy.
Bashari A, Siegfried Z, Karni R
RNA. 2023; 29(4):506-515.
PMID: 36697261
PMC: 10019363.
DOI: 10.1261/rna.079585.123.
Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition.
Potts K, Cameron R, Metidji A, Ghazale N, Wallace L, Leal-Cervantes A
Cell Rep. 2022; 41(11):111825.
PMID: 36516770
PMC: 9994853.
DOI: 10.1016/j.celrep.2022.111825.